The mechanism(s) by which glucose regulates glucagon secretion both acutely and in the longer term remain unclear. Added to isolated mouse islets in the presence of 0.5 mmol/l glucose, ␥-aminobutyric acid (GABA) inhibited glucagon release to a similar extent (46%) as 10 mmol/l glucose (55%), and the selective GABA A receptor (GABA A R) antagonist SR95531 substantially reversed the inhibition of glucagon release by high glucose. GABA A R ␣4, 3, and ␥2 subunit mRNAs were detected in mouse islets and clonal ␣TC1-9 cells, and immunocytochemistry confirmed the presence of GABA A Rs at the plasma membrane of primary ␣-cells. Glucose dose-dependently increased GABA A R expression in both islets and ␣TC1-9 cells such that mRNA levels at 16 mmol/l glucose were ϳ3.0-fold (␣4), 2.0-fold (3), or 1.5-fold (␥2) higher than at basal glucose concentrations (2.5 or 1.0 mmol/l, respectively). These effects were mimicked by depolarizing concentrations of K ؉ and reversed by the L-type Ca 2؉ channel blocker nimodipine. We conclude that 1) release of GABA from neighboring -cells contributes substantially to the acute inhibition of glucagon secretion from mouse islets by glucose and 2) that changes in GABA A R expression, mediated by changes in intracellular free Ca 2؉ concentration, may modulate this response in the long term. Diabetes 56: 320 -327, 2007